+1-888-308-5802     
News Contact Us

Eli Lilly to spin off its Greenfield-based animal health arm, Elanco

Author : Saipriya Iyer | Published Date : 2018-07-27 

Eli Lilly & Co., a leading pharmaceutical company has reportedly announced its plan to spin off its Greenfield-based animal health unit - Elanco, after going through a month-long review regarding its business in animal healthcare and agriculture. The company is expecting to complete the spinoff by the second half of this year, while the initial offering is anticipated to go public over the coming weeks.

Reportedly, the spinoff is considered to be one of the biggest strategic decisions taken by Dave Ricks, the Chief Executive Officer of Eli Lilly. The CEO revealed in a company statement that the decision for the spinoff had been taken mainly in favor of their shareholders.

For the record, Elanco sells medication for pets and livestock and had USD 3.09 billion in revenue last year. The company has scaled rapidly through its acquisition strategies, and have taken almost 10 companies since 2007 which includes the buyout of Novartis AG’s animal-health unit for USD 5.4 billion in 2015. A year after, the unit opened a 48,000-sq foot research facility next to its Greenfield Indiana, H.Q. to develop vaccines for livestock and pets.

According to the Eli Lilly, its per share earning has risen from $1.30 average in the second quarter to $1.50. The company has also raised its full-year adjusted earnings forecast from a $5.10 to $5.20 in June to $5.40 to $5.50 a share.

As per an official statement, the pharma company plans to offer less than 20% of Elanco stock in an initial public offering. The firm later plans to sell the remaining shares through a tax-efficient transaction.

Further, Lilly stated that the company doesn’t plan to increase the price of any drug for the whole year and will remain focused on gaining profit through volume and not through higher drug prices.

About Author

Saipriya Iyer

Saipriya Iyer

Saipriya Iyer presently works as a content developer for fractovia.org. Having dabbled with the domain of content creation for nearly half a decade, she now boasts of an enviable portfolio, holding substantial experience in penning down pieces related to technology, finance, and a wide spectrum of other industry verticals. A qualified computer engineering graduate from the University of Pune, Saipriya can often be found leveraging her knowledge of software technology and electronics in her write-ups. She can be contacted at- [email protected] | https://twitter.com/saipriya_i

Related News

Ramping production of lithium-ion batteries to accelerate tert-amylbenzene demand in Asia Pacific

Published Date: 2021-01-05         Author: Saipriya Iyer

As an active pharmaceutical ingredient (API) used in various clinical products to being used as an electronic additive in the making of lithium-ion batteries, tert amylbenzene (TAB) has gained wide-spread recognition across diverse industries. The chemical substance acts as a crucial intermediate in... Read More

FMCG firms to explore oral care market amidst rising hygiene concerns

Published Date: 2021-01-04         Author: Saipriya Iyer

Fast-moving consumer goods businesses in India are reportedly expanding their range of oral care, joining new and niche categories including mouthwashes, ayurvedic mouth cleansers, and mouth sprays as customer issues around general hygiene persists. For the record, Dabur India and Colgate Palmoli... Read More

Microsoft to introduce ‘Google assistant’ alternative for Windows

Published Date: 2020-12-28         Author: Saipriya Iyer

Microsoft Corporation, an American multinational technology giant, is reportedly testing a new voice launcher feature which will enable users to interact with files and applications using voice commands. According to trusted sources, the feature is currently available to select group of users who... Read More

© 2021 Fractovia. All Rights Reserved